183 related articles for article (PubMed ID: 29175121)
1. Elevated unmethylated and methylated insulin DNA are unique markers of A+β+ ketosis prone diabetes.
Mulukutla SN; Tersey SA; Hampe CS; Mirmira RG; Balasubramanyam A
J Diabetes Complications; 2018 Feb; 32(2):193-195. PubMed ID: 29175121
[TBL] [Abstract][Full Text] [Related]
2. Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.
Brooks-Worrell BM; Iyer D; Coraza I; Hampe CS; Nalini R; Ozer K; Narla R; Palmer JP; Balasubramanyam A
Diabetes Care; 2013 Dec; 36(12):4098-103. PubMed ID: 24130366
[TBL] [Abstract][Full Text] [Related]
3. Type 1 Diabetes Genetic Risk Score Differentiates Subgroups of Ketosis-Prone Diabetes.
Osafehinti D; Mulukutla SN; Hampe CS; Gaba R; Ram N; Weedon MN; Oram RA; Balasubramanyam A
Diabetes Care; 2023 Oct; 46(10):1778-1782. PubMed ID: 37506364
[TBL] [Abstract][Full Text] [Related]
4. Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect.
Zhang K; Lin G; Han Y; Xie J; Li J
Clin Epigenetics; 2017; 9():44. PubMed ID: 28450972
[TBL] [Abstract][Full Text] [Related]
5. Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-β+" ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection.
Nalini R; Ozer K; Maldonado M; Patel SG; Hampe CS; Guthikonda A; Villanueva J; O'Brian Smith E; Gaur LK; Balasubramanyam A
Metabolism; 2010 Oct; 59(10):1448-55. PubMed ID: 20170930
[TBL] [Abstract][Full Text] [Related]
6. High Prevalence of
Kubota-Mishra E; Huang X; Minard CG; Astudillo M; Refaey A; Montes G; Sisley S; Ram N; Winter WE; Naylor RN; Balasubramanyam A; Redondo MJ; Tosur M;
Pediatr Diabetes; 2024; 2024():. PubMed ID: 38765897
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Insulin Peptide-specific Interferon-γ-related Immune Responses in Ketosis-prone Type 2 Diabetes.
Satomura A; Oikawa Y; Haisa A; Suzuki S; Nakanishi S; Katsuki T; Shimada A
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2124-e2132. PubMed ID: 34922394
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of ketosis-prone diabetes.
Gaba R; Mehta P; Balasubramanyam A
Expert Rev Endocrinol Metab; 2019 Jan; 14(1):43-48. PubMed ID: 30612498
[TBL] [Abstract][Full Text] [Related]
9. β- and α-cell dysfunctions in africans with ketosis-prone atypical diabetes during near-normoglycemic remission.
Choukem SP; Sobngwi E; Boudou P; Fetita LS; Porcher R; Ibrahim F; Blondeau B; Vexiau P; Mauvais-Jarvis F; Calvo F; Gautier JF
Diabetes Care; 2013 Jan; 36(1):118-23. PubMed ID: 22933436
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics, beta-cell dysfunction and treatment outcomes in patients with A-β+ Ketosis-Prone Diabetes (KPD): The first identified cohort amongst Asian Indians.
Gupta RD; Ramachandran R; Gangadhara P; Anoop S; Singh SH; Satyaraddi A; Sathyakumar S; Asha HS; Thomas N
J Diabetes Complications; 2017 Sep; 31(9):1401-1407. PubMed ID: 28668376
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of patients with ketosis-prone diabetes (KPD) presenting with acute pancreatitis: implications for the natural history and etiology of a KPD subgroup.
Fernandez R; Misra R; Nalini R; Hampe CS; Ozer K; Balasubramanyam A
Endocr Pract; 2013; 19(2):243-51. PubMed ID: 23529349
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes.
Mulukutla SN; Acevedo-Calado M; Hampe CS; Pietropaolo M; Balasubramanyam A
Diabetes Care; 2018 Dec; 41(12):2637-2640. PubMed ID: 30327357
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics Profiling of Patients With A-β+ Ketosis-Prone Diabetes During Diabetic Ketoacidosis.
Jahoor F; Hsu JW; Mehta PB; Keene KR; Gaba R; Mulukutla SN; Caducoy E; Peacock WF; Patel SG; Bennet R; Lernmark A; Balasubramanyam A
Diabetes; 2021 Aug; 70(8):1898-1909. PubMed ID: 34021044
[TBL] [Abstract][Full Text] [Related]
14. Detection of islet β-cell death in vivo by multiplex PCR analysis of differentially methylated DNA.
Fisher MM; Perez Chumbiauca CN; Mather KJ; Mirmira RG; Tersey SA
Endocrinology; 2013 Sep; 154(9):3476-81. PubMed ID: 23825129
[TBL] [Abstract][Full Text] [Related]
15. A-beta-subtype of ketosis-prone diabetes is not predominantly a monogenic diabetic syndrome.
Haaland WC; Scaduto DI; Maldonado MR; Mansouri DL; Nalini R; Iyer D; Patel S; Guthikonda A; Hampe CS; Balasubramanyam A; Metzker ML
Diabetes Care; 2009 May; 32(5):873-7. PubMed ID: 19228875
[TBL] [Abstract][Full Text] [Related]
16. Ketosis-prone Diabetes and Hypogonadism: A New Clinical Association to be Aware of ?
Graziani A; Pollis RM; Bonora BM; Scaroni C; Sabbadin C
Endocr Metab Immune Disord Drug Targets; 2023; 23(12):1552-1556. PubMed ID: 37345245
[TBL] [Abstract][Full Text] [Related]
17. Glucokinase Gene May Be a More Suitable Target Than the Insulin Gene for Detection of β Cell Death.
Sklenarova J; Petruzelkova L; Kolouskova S; Lebl J; Sumnik Z; Cinek O
Endocrinology; 2017 Jul; 158(7):2058-2065. PubMed ID: 28525638
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with early relapse to insulin dependence in unprovoked A-β+ ketosis-prone diabetes.
Gaba R; Gambhire D; Uy N; Gonzalez EV; Iyer D; Hampe CS; Ram N; Balasubramanyam A
J Diabetes Complications; 2015; 29(7):918-22. PubMed ID: 26071380
[TBL] [Abstract][Full Text] [Related]
19. Remission in Ketosis-Prone Diabetes.
Kikani N; Balasubramanyam A
Endocrinol Metab Clin North Am; 2023 Mar; 52(1):165-174. PubMed ID: 36754492
[TBL] [Abstract][Full Text] [Related]
20. Elevations in Circulating Methylated and Unmethylated Preproinsulin DNA in New-Onset Type 1 Diabetes.
Fisher MM; Watkins RA; Blum J; Evans-Molina C; Chalasani N; DiMeglio LA; Mather KJ; Tersey SA; Mirmira RG
Diabetes; 2015 Nov; 64(11):3867-72. PubMed ID: 26216854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
